PE Ratio:
N/ASummary
- LGND price to earnings ratio is not available.
Performance
LGND PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
LGND PE Ratio Trends
| PeriodPeriod | PE RatioPE Ratio | PricePrice | TTM EPSTTM EPS | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | - | +0.6% | +43.9% | +3.4% |
| 1M1 Month | - | +9.2% | - | - |
| 3M3 Months | - | +42.5% | +43.9% | +3.4% |
| 6M6 Months | - | +69.7% | - | - |
| YTDYTD | - | +68.8% | - | - |
| 1Y1 Year | - | +74.9% | -272.9% | +40.5% |
| 5Y5 Years | - | +80.9% | -307.5% | +30.8% |
LGND PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | ||||
| 3M | 3-Month | ||||
| 6M | 6-Month | ||||
| 1Y | 1-Year | 51.68 | 41.16 | ||
| 3Y | 3-Year | 86.79 | 12.88 | ||
| 5Y | 5-Year | 86.79 | 12.88 | ||
| All-Time | All-Time | 1354.09 | 2.16 |
LGND PE Ratio History
| Date | Value |
|---|---|
| 2023 | 24.62(-47.1%) |
| 2021 | 46.58(+1212.1%) |
| 2019 | 3.55(-85.3%) |
| 2018 | 24.21(-91.0%) |
| Date | Value |
|---|---|
| 2017 | 270.45(+2575.1%) |
| 2015 | 10.11(-89.2%) |
| 2014 | 93.35(-24.6%) |
| 2013 | 123.74(+425.2%) |
| 2011 | 23.56 |
FAQ
- What is the all-time high PE ratio for Ligand Pharmaceuticals Incorporated?
What is the all-time high PE ratio for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high price to earnings ratio is 1354.09